Minimally Invasive Thoracic Surgery Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report 2026-2030

Minimally invasive thoracic surgery encompasses video-assisted thoracoscopic surgery (VATS), robotic-assisted thoracic surgery (RATS), and related procedures that replace traditional open thoracotomies with smaller incisions and specialized instrumentation. The thoracic surgery devices segment specifically, covering staplers, resection devices, and ablation systems, was valued at approximately $792 million to $799 million in 2025. When broader device categories including endoscopic, laparoscopic, navigation, and robotic assistive systems are included, the addressable market expands significantly within the overall surgical technology landscape.

• •Minimally invasive thoracic surgery market valued at $2.86 billion in 2025, projected toward $4.36-$6.24 billion by 2030
• •Thoracic surgery devices sub-segment valued at approximately $792-799 million in 2025, growing toward $1.37 billion by 2034 at ~6.3-6.4% CAGR
• •Broader minimally invasive surgery market reached approximately $94.8 billion in 2025, growing to $110 billion in 2026 at 16.1% CAGR

The aging global population is increasing the prevalence of thoracic conditions requiring surgical intervention, particularly lung cancer, which remains a primary indication for thoracic procedures. Advances in visualization, robotic assistance, and specialized stapling and dissection instruments are expanding the range of procedures that can be performed minimally invasively, driving adoption among thoracic surgeons. Clinical evidence demonstrating reduced blood loss, shorter hospital stays, lower infection rates, and faster patient recovery compared to open surgery continues to shift surgeon and hospital preference toward minimally invasive approaches.

• •Rising global incidence of thoracic cancers and chronic pulmonary conditions expanding the addressable patient population
• •Robotic-assisted platforms and enhanced imaging navigation enabling more complex procedures through minimally invasive access
• •Proven clinical and economic benefits, reduced complications, shorter hospitalizations, and faster rehabilitation, driving payer and provider adoption

The market is segmented by procedure type, including video-assisted thoracoscopic surgery and robotic-assisted thoracic surgery, with robotic platforms representing a faster-growing segment due to improved dexterity and three-dimensional visualization. Device categories encompass stapling and cutting devices, electrosurgical instruments, endoscopic tools, navigation systems, and visualization equipment. Geographically, North America and Europe currently dominate market share due to advanced healthcare infrastructure, higher procedure volumes, and favorable reimbursement frameworks, while Asia-Pacific is emerging as the fastest-growing regional market driven by expanding healthcare access, rising disease prevalence, and increasing investment in surgical technology capacity.

• •Regional concentration strongest in North America and Europe, with Asia-Pacific representing the fastest-growing market segment
• •Device segmentation includes staplers and resection devices, electrosurgical instruments, navigation and visualization systems, and robotic-assisted platforms
• •Robotic-assisted thoracic surgery is the highest-growth procedural segment, though VATS maintains the largest volume base

Who are the notable companies in the industry?

The competitive landscape of the global minimally invasive thoracic surgery market is moderately fragmented, shaped by a mix of large diversified medical technology firms and more specialized instrument manufacturers. Intuitive Surgical anchors the robotic-assisted segment with a vertically integrated platform strategy that bundles hardware, proprietary instrumentation, and software into a closed, high-margin ecosystem. Medtronic and Johnson & Johnson pursue broader, portfolio-driven approaches, leveraging cross-divisional strength across energy devices, mechanical stapling systems, three-dimensional visualization, and emerging robotic platforms to serve a wide procedural footprint. Where Intuitive Surgical's model emphasizes platform lock-in and recurring instrument revenue, Medtronic and Johnson & Johnson compete on interoperability, product breadth, and established clinical relationships. Primary technology routes span ultrasonic and radiofrequency energy devices, mechanical stapling and cutting systems, three-dimensional visualization and navigation platforms, and software-driven robotic assistance. Regional R&D and manufacturing capacity remains concentrated in North America, Western Europe, and Japan, with growing investment across China and the broader Asia-Pacific region.

• •Moderately fragmented market with mix of diversified medical technology companies and thoracic-focused specialty manufacturers
• •Technology routes span mechanical staplers, energy-based dissection instruments, visualization/navigation systems, and robotic-assisted platforms
• •Manufacturing and R&D capacity concentrated in North America, Western Europe, and Japan, with accelerating Asia-Pacific investment

What are the recent trends and outlook?

The market is positioned for sustained growth through 2030, with minimally invasive thoracic surgery increasingly becoming the standard of care for an expanding range of indications. Emerging trends include the integration of augmented reality and artificial intelligence into surgical navigation, single-port VATS techniques reducing incision count further, and the continued diffusion of robotic platforms into community hospital settings. As clinical evidence accumulates and reimbursement environments evolve, the shift from open to minimally invasive thoracic procedures is expected to accelerate across both developed and emerging markets.

• •Integration of augmented reality, AI-assisted navigation, and single-port techniques expected to expand the addressable procedure base
• •Robotic-assisted platforms continuing to penetrate beyond academic centers into community and regional hospital environments
• •Long-term growth supported by epidemiological trends, procedural standardization, and expanding global reimbursement alignment with minimally invasive approaches